Epsilon M&A Deal Report - Histalim
Transaction Multiples for the Valuation of Private Companies
Cerba Healthcare International / Histalim
No EMAT :
113797
Announced Date :
29/03/2018
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Cerba Healthcare International
Target :
Histalim
Country :
Hérault
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 2005, Histalim develops biomarkers that show a tumor’s immune profile, providing a diagnostic tool that is unique in Europe. > Histalim is also the first company in Europe to use complex...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | ns | ns | ns |
|
|
| Current |
|
ns | ns | ns | ns | ns |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 32
| Date | Acquirer | Target | Country | Multiples | See details |
| 18/06/2022 | Private Group led by Ardian | Groupe Simago | Paris | * | 113760 |
| 28/06/2022 | Private Group backed by Andera Partners | Groupe Resonance Imagerie SELAS | Val-D'Oise | * | 113731 |
Source: Epsilon Research / EMAT
